News

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since ...
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...